Mechanisms of altered excitation-contraction coupling in canine tachycardia-induced heart failure, I: Experimental studies

Circulation Research

Volumn 84, Issue 5, 1999, Pages 562-570

  O'Rourke, Brian ^a   Kass, David A ^a   Tomaselli, Gordon F ^a   Kääb, Stefan ^a   Tunin, Richard ^a   Marbán, Eduardo ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Action potential; Ca2+ uptake; Excitation contraction coupling; Heart failure; Sarcoplasmic reticulum

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); CALCIUM; CYCLOPIAZONIC ACID; PHOSPHOLAMBAN; SODIUM;

ACTION POTENTIAL; ADRENERGIC STIMULATION; ANIMAL CELL; ANIMAL MODEL; ARTICLE; CALCIUM MOBILIZATION; CALCIUM TRANSPORT; CELL MEMBRANE POTENTIAL; CONTROLLED STUDY; DOG; ENZYME REGULATION; EXCITATION CONTRACTION COUPLING; HEART FAILURE; IMMUNOBLOTTING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SARCOPLASMIC RETICULUM; VOLTAGE CLAMP;

EID: 0033583244     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.84.5.562     Document Type: Article

References (46)

1. Kääb S, Nuss HB, Chiamvimonvat N, O'Rourke B, Pak PH, Kass DA, Marban E, Tomaselli GF. Ionic mechanism of action potential prolongation in ventricular myocytes from dogs with pacing-induced heart failure. Circ Res. 1996;78:262-273.
2. Beuckelmann DJ, Nabauer M, Erdmann E. Intracellular calcium handling in isolated ventricular myocytes from patients with terminal heart failure. Circulation. 1992;85:1046-1055.
3. Li HG, Jones DL, Yee R, Klein GJ. Electrophysiologic substrate associated with pacing-induced heart failure in dogs: potential value of programmed stimulation in predicting sudden death. J Am Coll Cardiol. 1992;19:444-449.
4. Venneulen JT, McGuire MA. Opthof T, Coronel R, de BJM, Klopping C, Janse MJ. Triggered activity and automaticity in ventricular trabeculae of failing human and rabbit hearts. Cardiovasc Res. 1994;28:1547-1554.
5. + currents in isolated human ventricular myocytes from patients with terminal heart failure. Circ Res. 1993;73:379-385.
6. Nabauer M, Beuckelmann DJ, Erdmann E. Characteristics of transient outward current in human ventricular myocytes from patients with terminal heart failure. Circ Res. 1993;73:386-394.
7. Li HG, Jones DL, Yee R, Klein GJ. Arrhythmogenic effects of catecholamines are decreased in heart failure induced by rapid pacing in dogs. Am J Physiol. 1993;265(part 2):H1654-H1662.
8. Koumi S, Backer CL, Arentzen CE, Sato R. β-Adrenergic modulation of the inwardly rectifying potassium channel in isolated human ventricular myocytes. alteration in channel response to β-adrenergic stimulation in failing human hearts. J Clin Invest. 1995;96:2870-2881.
9. 2+, and glucagon. Am J Physiol. 1978;235: H690-H700.
10. Fowler MB, Laser JA, Hopkins GL, Minobe W, Bristow MR. Assessment of the β-adrenergic receptor pathway in the intact failing human heart: progressive receptor down-regulation and subsensitivity to agonist response. Circulation. 1986;74:1290-1302.
11. Feldman MD, Copelas L, Gwathmey JK, Phillips P, Warren SE, Schoen FJ, Grossman W, Morgan JP. Deficient production of cyclic AMP: pharmacologic evidence of an important cause of contractile dysfunction in patients with end-stage heart failure. Circulation. 1987;75:331-339.
12. Bohm M, Beuckelmann D, Brown L, Feiler G, Lorenz B, Nabauer M, Kemkes B, Erdmann E. Reduction of β-adrenoceptor density and evaluation of positive inotropic responses in isolated, diseased human myocardium. Eur Heart J. 1988;9:844-852.
13. Nabauer M, Bohm M, Brown L, Diet F, Eichhorn M, Kemkes B, Pieske B, Erdmann E. Positive inotropic effects in isolated ventricular myocardium from non-failing and terminally failing human hearts. Eur J Clin Invest. 1988;18:600-606.
14. Morgan JP. Intracellular calcium in heart failure. Cardiovasc Drugs Ther. 1988;1:621-624.
15. Gwathmey JK, Copelas L, MacKinnon R, Schoen FJ, Feldman MD, Grossman W, Morgan JP. Abnormal intracellular calcium handling in myocardium from patients with end-stage heart failure. Circ Res. 1987; 61:70-76.
16. Meuse AJ, Perreault CL, Morgan JP. Pathophysiology of cardiac hypertrophy and failure of human working myocardium: abnormalities in calcium handling. Basic Res Cardiol. 1992;87(suppl 1):223-233.
17. Perreault CL, Shannon RP, Komamura K, Vatner SF, Morgan JP. Abnormalities in intracellular calcium regulation and contractile function in myocardium from dogs with pacing-induced heart failure. J Clin Invest. 1992;89:932-938.
18. Hasenfuss G, Reinecke H, Studer R, Pieske B, Meyer M, Drexler H, Just H. Calcium cycling proteins and force-frequency relationship in heart failure. Basic Res Cardiol. 1996;91(suppl 2):17-22.
19. Pieske B, Hasenfuss G, Holubarsch C, Schwinger R, Bohm M, Just H. Alterations of the force-frequency relationship in the failing human heart depend on the underlying cardiac disease. Basic Res Cardiol. 1992; 87(suppl 1):213-221.
20. Phillips PJ, Gwathmey JK, Feldman MD, Schoen FJ, Grossman W, Morgan JP. Post-extrasystolic potentiation and the force-frequency relationship: differential augmentation of myocardial contractility in working myocardium from patients with end-stage heart failure. J Mol Cell Cardiol. 1990;22:99-110.
21. del Monte F, O'Gara P, Poole-Wilson PA, Yacoub M, Harding SE. Cell geometry and contractile abnormalities of myocytes from failing human left ventricle. Cardiovasc Res. 1995;30:281-290.
22. Davies CH, Davia K, Bennett JG, Pepper JR, Poole-Wilson PA, Harding SE. Reduced contraction and altered frequency response of isolated ventricular myocytes from patients with heart failure. Circulation. 1995;92: 2540-2549.
23. i-transients in single ventricular myocytes isolated from terminally failing human myocardium. Basic Res Cardiol. 1992;87(suppl 1):235-243.
24. i handling in human ventricular myocytes from patients with terminal heart failure. Am Heart J. 1995;129:684-689.
25. Hasenfuss G, Meyer M, Schillinger W, Preuss M, Pieske B, Just H. Calcium handling proteins in the failing human heart. Basic Res Cardiol. 1997;92(suppl 1):87-93.
26. Arai M, Alpert NR, MacLennan DH, Barton P, Periasamy M. Alterations in sarcoplasmic reticulum gene expression in human heart failure: a possible mechanism for alterations in systolic and diastolic properties of the failing myocardium. Circ Res. 1993;72:463-469.
27. 2+ ATPase and phospholamban mRNA and protein levels in end-stage heart failure due to ischemic or dilated cardiomyopathy. J Mol Med. 1996;74:321-332.
28. 2+-transporting ATPase, phospholamban, and calsequestrin levels in nonfailing and failing human myocardium. Circulation. 1994;90:653-657.
29. 2+-ATPase activity of cardiac sarcoplasmic reticulum from dilated cardiomyopathy patients compared with patients with nonfailing hearts. Circulation. 1995;92: 3220-3228.
30. 2+ uptake by cardiac sarcoplasmic reticulum from patients with idiopathic dilated cardiomyopathy. Circ Res. 1989;65:1141-1144.
31. 2+ exchanger in end-stage human heart failure. Circ Res. 1994;75:443-453.
32. 2+ exchanger in failing human myocardium. Circulation. 1996;94:992-1002.
33. 2+ exchanger in end-stage human heart failure. Ann N Y Acad Sci. 1996;779:543-545.
34. 2+ exchange activity in patients with end-stage heart failure. Cardiovasc Res. 1996;31:48-54.
35. Winslow RL, Rice J, Jafri S, Marbán E, O'Rourke B. Mechanisms of altered excitation-contraction coupling in canine tachycardia-induced heart failure, II: model studies. Circ Res. 1999;84:571-586.
36. Neher E. Correction for liquid junction potentials in patch clamp experiments. Methods Enzymol. 1992;207:123-131.
37. 2+ indicators with greatly improved fluorescence properties. J Biol Chem. 1985; 260:3440-3450.
38. Bassani JW, Bassani RA, Bers DM. Calibration of indo-1 and resting intracellular [Ca]i in intact rabbit cardiac myocytes. Biophys J. 1995;68: 1453-1460.
39. Bers DM. Excitation-Contraction Coupling and Cardiac Contractile Force. Dordrecht, the Netherlands: Kluwer Academic Publishing; 1991.
40. Hasenfuss G, Holubarsch C, Hermann HP, Astheimer K, Pieske B, Just H. Influence of the force-frequency relationship on haemodynamics and left ventricular function in patients with non-failing hearts and in patients with dilated cardiomyopathy. Eur Heart J. 1994;15:164-170.
41. Hasenfuss G, Preuss M, Lehnart S, Prestle J, Meyer M, Just H. Relationship between diastolic function and protein levels of sodium-calcium exchanger in end-stage failing human hearts. Circulation. 1996;94(suppl I):I-433.
42. 2+ release activity of the sarcoplasmic reticulum in dilated cardiomyopathy. Circulation. 1992;85:518-525.
43. 2+ accumulation in nonfailing and failing human myocardium. Circulation. 1995;92:2504-2510.
44. Gomez AM, Valdivia HH, Cheng H, Lederer MR, Santana LF, Cannell MB, McCune SA, Altschuld RA, Lederer WJ. Defective excitation-contraction coupling in experimental cardiac hypertrophy and heart failure. Science. 1997;276:800-806.
45. Piot C, Lemaire S, Albat B, Seguin J, Nargeot J, Richard S. High frequency-induced upregulation of human cardiac calcium currents. Circulation. 1996;93:120-128.
46. Fozzard HA. Afterdepolarizations and triggered activity. Basic Res Cardiol. 1992;87(suppl 2):105-113.